The effect of COVID-19 vaccinations on menstrual cycle and serum anti-Mullerian hormone levels in reproductive age women
The aim of this prospective cohort study was to investigate the effect of coronavirus disease 2019 (COVID-19) vaccinations on menstrual cycle and ovarian reserve in reproductive aged-women. Health care providers (n = 258) vaccinated with inactivated (CoronaVac) and mRNA based (Pfizer-BioNTech®) COVID-19 vaccines were included. All subjects completed a gynaecological and menstrual history questionnaire and Anti-Mullerian Hormone (AMH) levels were measured in serum samples collected before first vaccination and at 1st, 3rd, 6th and 9th months. The prevalence of new-onset menstrual dysregulation following vaccination was 20.6% and it was statistically significant compared to baseline (p = 0.001). Menstrual pattern turned back to normal in 59.6% of vaccinated women. Serum AMH levels gradually decreased until 6th month of follow-up compared to baseline (p < 0.001). A significant increase in serum AMH level was observed at 9th month of follow-up compared to 6th month follow-up levels (p < 0.001). The decrease in serum AMH level was statistically significant regardless of serum anti SARS-CoV-2 antibody levels, subgroups of age, occupation, menstrual dysregulation following vaccination and presence of gynaecological diseases. In conclusion, vaccination against SARS-CoV-2 causes a transient decrease on serum AMH levels and moderate irregularities in menstrual pattern increasing with age and is mostly reversible.
| Errataetall: |
CommentIn: Hum Fertil (Camb). 2023 Feb;26(1):186. - PMID 37102569 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Human fertility (Cambridge, England) - 26(2023), 1 vom: 04. Feb., Seite 153-161 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hasdemir, Pinar Solmaz [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
80497-65-0 |
|---|
| Anmerkungen: |
Date Completed 02.06.2023 Date Revised 06.09.2023 published: Print-Electronic CommentIn: Hum Fertil (Camb). 2023 Feb;26(1):186. - PMID 37102569 Citation Status MEDLINE |
|---|
| doi: |
10.1080/14647273.2023.2181710 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354249630 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354249630 | ||
| 003 | DE-627 | ||
| 005 | 20231226061815.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14647273.2023.2181710 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1180.xml |
| 035 | |a (DE-627)NLM354249630 | ||
| 035 | |a (NLM)36919413 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hasdemir, Pinar Solmaz |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The effect of COVID-19 vaccinations on menstrual cycle and serum anti-Mullerian hormone levels in reproductive age women |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.06.2023 | ||
| 500 | |a Date Revised 06.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Hum Fertil (Camb). 2023 Feb;26(1):186. - PMID 37102569 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The aim of this prospective cohort study was to investigate the effect of coronavirus disease 2019 (COVID-19) vaccinations on menstrual cycle and ovarian reserve in reproductive aged-women. Health care providers (n = 258) vaccinated with inactivated (CoronaVac) and mRNA based (Pfizer-BioNTech®) COVID-19 vaccines were included. All subjects completed a gynaecological and menstrual history questionnaire and Anti-Mullerian Hormone (AMH) levels were measured in serum samples collected before first vaccination and at 1st, 3rd, 6th and 9th months. The prevalence of new-onset menstrual dysregulation following vaccination was 20.6% and it was statistically significant compared to baseline (p = 0.001). Menstrual pattern turned back to normal in 59.6% of vaccinated women. Serum AMH levels gradually decreased until 6th month of follow-up compared to baseline (p < 0.001). A significant increase in serum AMH level was observed at 9th month of follow-up compared to 6th month follow-up levels (p < 0.001). The decrease in serum AMH level was statistically significant regardless of serum anti SARS-CoV-2 antibody levels, subgroups of age, occupation, menstrual dysregulation following vaccination and presence of gynaecological diseases. In conclusion, vaccination against SARS-CoV-2 causes a transient decrease on serum AMH levels and moderate irregularities in menstrual pattern increasing with age and is mostly reversible | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Anti-mullerian hormone | |
| 650 | 4 | |a COVID-19 vaccine | |
| 650 | 4 | |a Pfizer-biontech | |
| 650 | 4 | |a menstrual cycle | |
| 650 | 4 | |a sinovac-coronavac | |
| 650 | 7 | |a Anti-Mullerian Hormone |2 NLM | |
| 650 | 7 | |a 80497-65-0 |2 NLM | |
| 650 | 7 | |a sinovac COVID-19 vaccine |2 NLM | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Senol Akar, Sebnem |e verfasserin |4 aut | |
| 700 | 1 | |a Goker, Asli |e verfasserin |4 aut | |
| 700 | 1 | |a Kosova, Funda |e verfasserin |4 aut | |
| 700 | 1 | |a Ucar, Duygu |e verfasserin |4 aut | |
| 700 | 1 | |a Ozalp Ates, Funda Seher |e verfasserin |4 aut | |
| 700 | 1 | |a Akcali, Sinem |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Human fertility (Cambridge, England) |d 1998 |g 26(2023), 1 vom: 04. Feb., Seite 153-161 |w (DE-627)NLM114857482 |x 1742-8149 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2023 |g number:1 |g day:04 |g month:02 |g pages:153-161 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14647273.2023.2181710 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2023 |e 1 |b 04 |c 02 |h 153-161 | ||